http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2614072-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2205-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2201-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2201-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2039-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H39-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2201-12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H39-007
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2006-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90b7a2cb7a1be9537657b74f6ae24c42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05831d7cc422587c6bcc507234be0781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a7b8d268072de5c2b79f6e56d65814d
publicationDate 2007-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2614072-A1
titleOfInvention Systems and methods for recovery of motor control via stimulation to a substituted site for an affected area
abstract A method for recovering motor control of an area in the body of a patient affected by a neurological disorder comprising stimulating a substitute site for said area thereby recovering the motor control of said affected area, wherein said stimulating of said substitute site is volitionally controlled by said patient is described.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419784-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11229576-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413214-B2
priorityDate 2005-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390989
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID394422
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID779122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID783320
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11355923

Total number of triples: 37.